Guide 01

Your research path, from first question to final follow-up.

Study experiences differ, but the decision points below can help you recognize what to expect and what to ask.

Finding a possible study

You may hear about research from a clinician, patient organization, online listing, community event, or research site. A listing is a starting point, not a determination that a study is suitable for you. Confirm the official study title, sponsor or institution, location, contact information, and recruiting status.

Eligibility criteria may include age, diagnosis, test results, treatment history, medications, or other health factors. These rules exist to protect participants and help researchers answer a defined question. Only an authorized study team can complete screening and decide whether the criteria are met.

Screening and consent

Screening may involve a brief call followed by review of health history, records, laboratory results, or examinations. Ask which screening activities are research-only, which may be billed to you or your insurer, and whether results will be shared with you. Do not assume that passing an initial phone screen guarantees enrollment.

Before research-specific procedures begin, the team should explain the informed-consent document. It generally covers the purpose, duration, procedures, foreseeable risks, potential benefits, alternatives, privacy practices, costs, compensation, injury information, and contacts. Take the time you need. You may ask to discuss the document with family, a trusted person, or your healthcare professional.

Important: Consent is voluntary. Declining a study should not affect the medical care to which you are otherwise entitled.

During the study

Follow the visit schedule and instructions provided by the study team, and report symptoms or changes honestly. Keep the study contact information accessible. Ask whether there is a 24-hour number for urgent study-related concerns. Continue routine healthcare unless the study team and your treating clinician advise otherwise.

Some studies use randomization, which assigns participants to groups by chance. Some use a placebo or comparison treatment. Blinding may limit who knows which assignment a participant receives. The team should explain whether these features apply and what standard care or rescue treatment remains available.

After participation

Follow-up may continue after the study intervention ends. Ask how long researchers will contact you, what happens to specimens and data, whether individual results are returned, and whether a summary of overall results may become available. Your participation contributes information, but no study can promise a specific personal outcome.